Hipa.ai - 2026 Pricing, Features, Reviews & Alternatives

Hipa.ai is a cloud-based US healthcare data platform hosted on Microsoft Azure, combining three interconnected products for behavioral health professionals, clinical researchers, and workforce analysts. The first product is an AI-powered clinical documentation tool for ABA professionals, generating assessment reports, treatment plans, session notes, prior authorization requests, progress reports, supervision notes, and behavior intervention plans by populating templates from user-provided data. All AI-generated documents require professional review and approval before clinical use, and clinical data and PHI are never used to train AI models. HIPAA-compliant infrastructure includes AES-256 encryption at rest and in transit, role-based access control, multi-factor authentication support, and audit logging. Multi-organization workspaces support separate billing, team membership, and content strategy per organization.

The second product is a clinical trials discovery directory aggregating thousands of actively recruiting paid studies across all 50 US states, with data sourced from ClinicalTrials.gov and refreshed daily. Listings are searchable by state, city, condition, therapeutic area, phase, age, and healthy-volunteer eligibility. Trial listings link directly to sponsoring research site contact details with no data gating and no registration required, giving sponsors and research organizations direct access to qualified volunteers from first contact. A public, read-only Model Context Protocol (MCP) endpoint at hipa.ai/mcp exposes live US clinical trials data to any MCP-compatible AI client with no authentication required.

The third product is an ABA workforce intelligence hub providing job listings for BCBAs and RBTs, salary benchmarks by state and city (25th to 75th percentile ranges), company profiles, and weekly BCBA and RBT hiring reports sourced from the CMS NPI registry. Together, the three products serve BCBAs, RBTs, ABA clinics and practices, US adults seeking clinical trial opportunities, and clinical research sponsors and contract research organizations seeking broader trial discoverability.